Cisplatin, Fluorouracil, and Pembrolizumab

About

Membership operator: AND

Therapies: 3

Therapies

Cisplatin (tx:ncit:C376)

Fluorouracil (tx:ncit:C505)

Pembrolizumab (tx:ncit:C106432)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy group.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
FDA (2) HC (1) HER2-negative Adenocarcinoma of the Gastroesophageal Junction Cisplatin, Fluorouracil, Pembrolizumab